Filter
843
Text search:
drug
toxicity
Featured
Recommendations
120
New Publications
213
Language
Document type
No document type
487
Guidelines
177
Studies & Reports
112
Manuals
38
Training Material
17
Fact sheets
8
Strategic & Response Plan
2
Situation Updates
1
Infographics
1
Countries / Regions
India
62
Kenya
27
Ethiopia
26
Global
21
South Africa
17
Nepal
15
Zambia
14
Tanzania
14
Uganda
11
Rwanda
11
Namibia
11
Ghana
9
Latin America and the Carribbean
9
Western and Central Europe
9
Sierra Leone
8
Philippines
8
Myanmar / Burma
8
Africa
7
Nigeria
6
Zimbabwe
6
Bangladesh
6
Eswatini/ Swaziland
6
Eastern Europe
6
Cambodia
5
Malawi
5
South–East Asia Region
5
Ukraine
4
Botswana
4
Lesotho
4
Asia
4
Liberia
3
USA
3
Thailand
3
Russia
3
South Sudan
2
Germany
2
Colombia
2
Western Pacific Region
2
Senegal
1
Congo, Democratic Republic of
1
Cameroon
1
Iraq
1
Syria
1
Gambia
1
Papua New Guinea
1
Brazil
1
North Macedonia
1
Bolivia
1
Angola
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Fiji
1
Mongolia
1
Laos
1
Estonia
1
Iran
1
Australia
1
Georgia
1
North America
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
286
Clinical Guidelines
147
Public Health
34
Women & Child Health
32
Capacity Building
15
Key Resources
12
Pharmacy & Technologies
10
Toolboxes
HIV
137
TB
102
Mental Health
61
Pharmacy
53
NTDs
48
AMR
37
COVID-19
24
Caregiver
14
Planetary Health
13
Specific Hazards
9
NCDs
9
Rapid Response
8
Refugee
7
Malaria
7
Ebola & Marburg
6
Conflict
5
Global Health Education
5
Polio
4
Disability
2
2.0 Rapid Response
2
Natural Hazards
1
Zika
1
Health Financing Toolbox
1
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Policy brief. July 2020
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an
...
An update from the EU Early Warning System
AIDSTAR-One | CASE STUDY SERIES November 2012
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra
...
2nd edition
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...